Literature DB >> 11568179

CCAAT/enhancer-binding protein alpha alters histone H3 acetylation at large subnuclear domains.

W H Zhang1, R Srihari, R N Day, F Schaufele.   

Abstract

Transcriptional regulation is commonly associated with local levels of histone acetylation, which controls chromatin structure at specific genes or within contiguous chromosomal domains. Less well understood are the higher order determinants of histone acetylation. The transcription factor, CCAAT/enhancer-binding protein alpha (C/EBPalpha), concentrates at one higher order structure, the peri-centromeric chromatin, and regulates differentiation in many cell types, including pituitary cells. We used quantitative fluorescence microscopy to show that immunostained acetylated histone H3 is relatively absent from peri-centromeric domains visible as large structures in mouse pituitary progenitor GHFT1-5 cells. GHFT1-5 cells do not contain C/EBPalpha. We observed that expression of C/EBPalpha in GHFT1-5 cells leads to an increased level of acetylated histone H3, but not acetylated histone H4, at the peri-centromeric domains. Only transcriptionally active forms of C/EBPalpha altered histone acetylation at the peri-centromeric domain. The altered state of histone acetylation at large intranuclear domains may complement, counteract, or supersede the more gene-local activities of other transcription factors to coordinate C/EBPalpha-induced cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568179     DOI: 10.1074/jbc.C100505200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Astrocyte- and hepatocyte-specific expression of genes from the distal serpin subcluster at 14q32.1 associates with tissue-specific chromatin structures.

Authors:  Sunita Gopalan; Aneta Kasza; Weili Xu; Daniel L Kiss; Katarzyna M Wilczynska; Russell E Rydel; Tomasz Kordula
Journal:  J Neurochem       Date:  2005-06-22       Impact factor: 5.372

2.  Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.

Authors:  Hong Duan; Caroline A Heckman; Linda M Boxer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression.

Authors:  Corina Heller; Tanja Weisser; Antje Mueller-Schickert; Elke Rufer; Alexander Hoh; Ralf M Leonhardt; Michael R Knittler
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

Review 4.  Is it important to decipher the heterogeneity of "normal karyotype AML"?

Authors:  Stephen D Nimer
Journal:  Best Pract Res Clin Haematol       Date:  2008-03       Impact factor: 3.020

5.  A PIT-1 homeodomain mutant blocks the intranuclear recruitment of the CCAAT/enhancer binding protein alpha required for prolactin gene transcription.

Authors:  John F Enwright; Margaret A Kawecki-Crook; Ty C Voss; Fred Schaufele; Richard N Day
Journal:  Mol Endocrinol       Date:  2003-02

6.  Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation.

Authors:  Mei Nie; Linhua Pang; Hiroyasu Inoue; Alan J Knox
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

7.  Type-3 ryanodine receptors mediate hypoxia-, but not neurotransmitter-induced calcium release and contraction in pulmonary artery smooth muscle cells.

Authors:  Yun-Min Zheng; Qing-Song Wang; Rakesh Rathore; Wan-Hui Zhang; Joseph E Mazurkiewicz; Vincenzo Sorrentino; Harold A Singer; Michael I Kotlikoff; Yong-Xiao Wang
Journal:  J Gen Physiol       Date:  2005-04       Impact factor: 4.086

8.  CCAAT/enhancer binding protein alpha uses distinct domains to prolong pituitary cells in the growth 1 and DNA synthesis phases of the cell cycle.

Authors:  Weiqun Liu; John F Enwright; William Hyun; Richard N Day; Fred Schaufele
Journal:  BMC Cell Biol       Date:  2002-03-21       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.